期刊文献+

子宫癌肉瘤26例临床病理及预后影响因素分析 被引量:13

Clinical pathology and prognostic factors of carcinosarcomas of uterus:an analysis of 26 cases
下载PDF
导出
摘要 目的探讨子宫癌肉瘤的临床病理特征及预后影响因素。方法收集1997年1月~2004年12月在复旦大学附属妇产科医院诊治的26例子宫癌肉瘤患者的临床病理资料,进行预后影响因素分析。结果26例患者平均年龄59.5岁,20例(76.9%)患者已绝经,主要症状是异常阴道流血。手术时,21例(80.8%)患者未发现残留病灶,其中10例(47.6%)术后出现复发,平均缓解期为15个月,平均生存时间18个月。26例患者均获得随访,总5年生存率26.5%,中位生存时间(33±7.33)个月,其中临床分期Ⅰ、Ⅱ、Ⅲ、Ⅳ期患者的5年生存率分别为79.1%、37.5%、13.3%、0,且Ⅰ+Ⅱ期的5年生存率明显高于Ⅲ+Ⅳ期(P=0.006)。单因素分析显示:肿瘤大小、肌层浸润深度、有无淋巴结转移、有无残留病灶以及临床病理分期均与预后相关。多因素分析显示:临床病理分期是独立的预后影响因素(P=0.035)。结论子宫癌肉瘤是侵袭性肿瘤,易发生子宫外播散、转移。临床病理分期是独立的预后影响因素,提高早期检出率,改进治疗措施对提高子宫癌肉瘤的生存率有重要意义。 Purpose To review the clinicopathological features and to identify prognostic factors in uterine carcinosarcomas. Methods Twenty-six cases of of the uterus were studied retrospectively at Fudan University affiliated Obstetric and Gynecologic Hospital from January 1997 to December 2004. Results Twenty-six patients with median age of 59. 5 years were analyzed, in which twenty (76. 9% ) were menopausal. Abnormal vaginal bleeding was the most common symptom. There were nine patients with stage Ⅰ, five with stage Ⅱ , ten with stage Ⅲ and two with stage Ⅳ disease. There was a significantly difference of survival distribution between the low-stage group ( stages Ⅰ and ) and the high-stage group ( stages Ⅲ and Ⅳ ) ( P = 0. 006). At the completion of primary surgery, 21 (80. 8% ) patients had no macroscopic residual tumors, Ten (47. 6% ) of these patients had recurrence of disease, the median disease-free time was 15 months, and median overall survival was 18 months. All patients were followed up with median overall survival of 33 months, a 5-year survival rate of 26. 5% for all stages. Univariate analysis showed that clinicopathological variables including tumor size, depth of myometrial invasion, residual disease, positive lymph node, surgical stage have a significant association with overall survival. Multivariate analysis using the Cox proportional hazards model showed that only surgical stage remained a significant independent predictive variable ( P = 0. 035 ). Conclusions Uterine carcinosarcoma is a rare aggressive tumor with a high tendency to spread and high relapse rate resulting in extremely poor overall survival. In this study, although the number of cases is small, the surgical stage is an independent factor in prediction of survival in uterine carcinosarcoma. Survival rate remains to be improved.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2007年第5期520-523,共4页 Chinese Journal of Clinical and Experimental Pathology
关键词 子宫肿瘤 癌肉瘤 病理诊断 预后 uterine neoplasms carcinosarcoma pathologic diagnosis prognosis
  • 相关文献

参考文献12

  • 1Arrastia C, Fruchter R, Clark M, et al. Uterine carcinosarcomas. Incidence and trends in management and survival [J]. Gynecol Oncol, 1997,65:158 - 163.
  • 2Silverberg S G, Major F J, Blessing J A, et al. Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus. A gynecologic oncology group pathologic study of 203 cases [J]. Int J Gynecol Pathol, 1990, 9: 1 - 19.
  • 3Robboy S J, Anderson M C, Russell P. Pathology of the Female Reproductive Tract [M]. London : Churchill Livingstone, 2002.
  • 4Chuang J T, Van Velden D J, Graham J B. Carcinosarcoma and mixed mesodermal tumor of the uterine corpus. Review of 49 cases [J]. Obstet Gynecol, 1970, 35:769-780.
  • 5Dinh T V, Slavin R E, Bhagavan B S, et al. Mixed me'ullerian tumors of the uterus: a clinicopathologic study[J]. Obstet Gynecol, 1989, 274:388-392.
  • 6Amant F, Cadron I, Fuso L, et al. Endometrial have a different prognosis and pattern of spread compared to high-risk epithelial endometfial cancer [J]. Gynecol Oncol, 2005,98 (2) : 274 -280.
  • 7Macasaet M A, Waxman M, Fruchter R G, et al. Prognostic factors in malignant mesodermal (mullerian) mixed tumors of the uterus[J]. Gynecol Oncol ,1985, 20:32 -42.
  • 8Yamada S D, Burger R A, Brewster W R, et al. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus [J]. Cancer,2000, 88:2782-2786.
  • 9lwasa Y, Haga H, Konishi I, et al. Prognostic factors in uterine carcinosarcoma[J]. Cancer, 1998, 82 : 512 - 519.
  • 10Gourley C, Al-Nafussi A, Abdulksder M, et al. Malignant mixed mesodermal tomours: biology and clinical aspects[J]. Eur J Caner 2002,38: 1437 - 1446.

同被引文献71

  • 1唐涛,范嫏娣,郭东辉,达小萍.子宫内膜间质肿瘤临床病理分析[J].诊断病理学杂志,2004,11(3):150-153. 被引量:21
  • 2朱英坚,叶敏,王伟明,祝明洁,姚晓虹,陈方.膀胱癌肉瘤的临床特征(附2例报告并文献复习)[J].临床泌尿外科杂志,2005,20(1):56-57. 被引量:6
  • 3吴婉莉,楼洪坤.子宫癌肉瘤24例临床分析[J].中华肿瘤杂志,2005,27(3):170-170. 被引量:6
  • 4舒宽勇,艾小燕,李隆玉,黄山鹰.子宫颈小细胞癌24例临床病理分析[J].实用临床医学(江西),2005,6(6):64-67. 被引量:4
  • 5张红莺,李燕,石群立,周晓军,孟奎,陆珍风,孙慧敏.原发性子宫颈小细胞癌6例临床病理研究[J].诊断病理学杂志,2005,12(6):423-425. 被引量:4
  • 6Fattaneh A,Tavassoli,Devilee P.世界卫生组织肿瘤分类及诊断标准系列:乳腺及女性生殖器官肿瘤病理学和遗传学[M].北京:人民卫生出版社,2006.306-309.
  • 7Arrastia CD,Fruchter RG,Clark M,et al.Uterine carcinosarcomas:incidence and trends in management and survival[J].Gynecol Oneol,1997,65(1):158-163.
  • 8Mccluggage WG.Magligant biphasic uterine tumours:cacinoscarcomas or metaplastic carcinomas[J]? Clin Patho,2002,55:321-325.
  • 9Lopez-Beltran A,Pacelli A,Rothenberg H J,et al.carcinosarcoma and sarcomatoid carcinoma of the bladder:clinicopathological study of 41 cases[J].J Urol,1998,159(5):1497-503.
  • 10Gronau S,Menz C K,Melzner I,et al.Immunohistomorphologic and molecular cytogenetic analysis of a carcinosarcoma of the urinary bladder[J].Virchows Arch,2002,440(4):436-40.

引证文献13

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部